Rapid Communication
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 14, 2006; 12(26): 4246-4249
Published online Jul 14, 2006. doi: 10.3748/wjg.v12.i26.4246
Table 1 Relationship between hereditary instability of BRCA1 gene at locus D17S855 and clinicopathological parameters of gastric cancer
Clinicopatho- logical parametersCase (n)MSI positive rates (%)LOH positive rates (%)BRCA1 positive rates (%)BRCA1 expression (PU Mean±S)
Histology377 (18.92%)7 (18.92%)14 (37.84%)33.56 ± 2.23
Tubuladenoma306 (20.00%)6 (20.00%)12 (40.00%)32.87 ± 2.93
High
differentiation94 (44.44%) 1 (7.69%)1 (11.11%)7 (77.78%)a34.03 ± 1.79
Middle
differentiation131 (12 .50 %)1 (7.69%)4 (30.77%)33.49 ± 2.34
Low
differentiation81 (14.29%)4 (50.00%)1 (12.50%)33.58 ± 1.67
Mucoadenoma71 (14.29%)2 (28.57%)32.87 ± 2.59
Lymph metastasis
No175 (29.41%)1 (5.88%)9 (52.94%)34.75 ± 1.78
Yes202 (10.00%)6 (30.00%)5 (25.00%)33.14 ± 2.14
TNM staging
Stage I + II196 (31.58%)1 (5.26%)11 (57.89%)33.88 ± 2.38
Stage III + IV181 (5.56%)a6 (33.33%)a3 (16.67%)a33.23 ± 2.34
Table 2 Relationship between MSI, LOH of BRCA1 gene at locus D17S855 and BRCA1 protein expression
GroupingCasesBRCA1 proteinpositive ratesBRCA1 expression(PU Mean±S)
MSI positive group785.71% (6/7)34.05 ± 1.91
MSI negative group3026.67% (8/30) a32.59 ± 2.23
LOH positive group728.57% (2/7)32.87 ± 2.35
LOH negative group3040.00% (12/30)34.03 ± 2.66